D'Avino, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 1.349
EU - Europa 1.317
AS - Asia 786
SA - Sud America 152
AF - Africa 22
OC - Oceania 2
Totale 3.628
Nazione #
US - Stati Uniti d'America 1.306
DE - Germania 411
SG - Singapore 366
PL - Polonia 216
FR - Francia 194
CN - Cina 193
SE - Svezia 143
BR - Brasile 124
IT - Italia 111
UA - Ucraina 82
VN - Vietnam 66
GB - Regno Unito 54
IN - India 45
IE - Irlanda 35
CA - Canada 28
ID - Indonesia 23
FI - Finlandia 21
TR - Turchia 17
JP - Giappone 16
RU - Federazione Russa 16
HK - Hong Kong 12
AR - Argentina 11
BD - Bangladesh 10
ZA - Sudafrica 8
BE - Belgio 6
IQ - Iraq 6
IR - Iran 6
ES - Italia 5
MX - Messico 5
NL - Olanda 5
EC - Ecuador 4
SA - Arabia Saudita 4
VE - Venezuela 4
AT - Austria 3
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
JM - Giamaica 3
KR - Corea 3
LT - Lituania 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
MA - Marocco 2
PS - Palestinian Territory 2
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.628
Città #
Kraków 210
Chandler 203
Singapore 177
Ashburn 113
San Jose 88
Jacksonville 68
New York 59
San Mateo 42
Redmond 37
Los Angeles 36
Dublin 35
Beijing 34
Milan 30
Ann Arbor 29
Cattolica 27
Ho Chi Minh City 27
Nürnberg 26
Wilmington 26
Nanjing 25
Dearborn 24
Lauterbourg 23
The Dalles 23
Jakarta 22
Dallas 20
Houston 20
Lawrence 18
Woodbridge 18
Boston 17
Hanoi 14
Izmir 13
Nanchang 13
Ottawa 13
Tokyo 13
Lancaster 12
Changsha 11
Fairfield 11
Redwood City 11
Buffalo 10
Chicago 10
Frankfurt am Main 10
Hong Kong 10
Munich 9
Shenyang 9
São Paulo 9
Kunming 8
Rome 8
Shanghai 8
Augusta 7
Falls Church 7
London 7
Seattle 7
Brussels 6
Fremont 6
Hebei 6
Hefei 6
Johannesburg 6
Montreal 6
Mountain View 6
Orem 6
Bexley 5
Guangzhou 5
Hangzhou 5
Leawood 5
Marseille 5
Roubaix 5
Santa Clara 5
Tianjin 5
Toronto 5
Verona 5
Amsterdam 4
Bari 4
Boardman 4
Bremen 4
Brooklyn 4
Cambridge 4
Da Nang 4
Jinan 4
Kish 4
Manchester 4
Mexico City 4
Moscow 4
Paris 4
Pune 4
Rio de Janeiro 4
University Park 4
Warsaw 4
Washington 4
Ankara 3
Atlanta 3
Baku 3
Biên Hòa 3
Caracas 3
Dhaka 3
Fuzhou 3
Modena 3
Phoenix 3
Princeton 3
Tunis 3
Almirante Tamandaré 2
Amman 2
Totale 1.914
Nome #
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 268
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 218
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 218
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 217
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 210
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 202
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 194
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 189
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 186
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 185
Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy 176
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 167
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study 166
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 154
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 149
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 142
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 136
Coccidioidomycosis of cervical lymph nodes in an HIV-infected patient with immunologic reconstitution on potent HAART: a rare observation in a nonendemic area 132
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 125
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 122
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 109
Totale 3.665
Categoria #
all - tutte 12.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 5 30 3
2021/2022245 18 18 6 20 11 19 3 44 13 28 29 36
2022/2023457 65 77 29 79 35 54 8 45 57 1 5 2
2023/2024231 12 66 4 26 14 59 10 0 3 3 25 9
2024/2025425 5 18 22 22 62 15 0 32 84 34 74 57
2025/2026899 143 15 52 116 196 44 171 53 45 64 0 0
Totale 3.665